Video: Knock on Wood| Webinar: ACR/CHEST ILD Guidelines in Practice
fa-facebookfa-linkedinfa-youtube-playfa-rss

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Lupus Nephritis
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Search results for: osteoporosis

Rheumatologist’s Passion for Gardening Keeps Plants, Patients Healthy

Carol Patton  |  October 18, 2017

Deborah Dyett Desir, MD, vividly remembers her first day as an undergraduate student at Harvard University, Boston. When her parents helped her move into the dorm, her mother, Betty, handed her a beautiful begonia. “My response was, ‘What on earth am I going to do with this plant?’” she says, recalling how she examined the…

Filed under:AudioConditionsOsteoarthritis and Bone DisordersRheum After 5 Tagged with:Arthritis & Osteoporosis Center PCDr. Deborah Dyett DesirhobbyOsteoporosispatient careProfilerheumatologist

Ethics Forum: A Physician’s Medical Error & the Patient’s Right to Know

Sian Yik Lim, MD, & Marcy B. Bolster, MD  |  October 17, 2017

Case Ms. A is an 82-year-old woman who presented to the rheumatology office for evaluation of osteoporosis. She had been diagnosed with postmenopausal osteoporosis at age 62 after sustaining a right wrist fracture. She was started on alendronate 70 mg weekly and reported medication compliance. At age 79, she sustained an atraumatic right femur fracture….

Filed under:EthicsProfessional Topics Tagged with:disclosureEthicsMedical decision makingmedical errorpatient carepatient satisfactionphysicianphysician-patient communicationrheumatologistrheumatology

New Data May Explain the Role of Sclerostin in Bone Formation

Lara C. Pullen, PhD  |  October 9, 2017

New research in mice shows that sclerostin deficiency may play a significant role in bone formation, possibly despite skeletal age. In the study, sclerostin-deficient mice more readily formed cortical bone and had increases in periosteal bone formation rates, as well as increased expression of the Wnt inhibitor Dkk1, than controls…

Filed under:ConditionsOsteoarthritis and Bone Disorders Tagged with:bonebone formationOsteoporosissclerostin

What Price Glory (or, at Least, Getting Your Foot in the Door)?

Gerald Eisenberg  |  October 4, 2017

In many respects, this is the beginning of the golden age of rheumatology. Diagnostic and therapeutic approaches are now available that have radically altered for the better the lives of people with diseases that were considered virtually untreatable just a few years ago. The rheumatologist’s approach to patients with rheumatoid arthritis, the spondyloarthropathies, osteoporosis and…

Filed under:Legislation & AdvocacyProfessional Topics Tagged with:Capitol HillIllinois Bone and Joint Institute (IBJI)RheumPACRheumPAC donors

Undetected Fractures Linked to Back Pain in Older Men

Shereen Lehman  |  September 22, 2017

(Reuters Health)—About three in five older men with tiny spinal fractures related to osteoporosis reported new or worsening back pain in a new study. Only about one-quarter of new vertebral fractures are diagnosed by a doctor, the study team writes in their September 7 online report in Journal of Bone and Mineral Research, though the…

Filed under:ConditionsOsteoarthritis and Bone Disorders Tagged with:Back painFracturesOsteoporosisundetected fracturesvertebral fracture

Abatacept Plus Prednisone Therapy Studied for Treating Giant Cell Arteritis

Linda Childers  |  September 17, 2017

A recent study, conducted by the Vasculitis Clinical Research Consortium and funded by the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), examined whether the addition of abatacept, a drug that affects T cell activation, to standard prednisone treatment could reduce the risk of relapse in patients with giant cell arteritis (GCA).1 Although…

Filed under:ConditionsResearch RheumVasculitis Tagged with:abataceptACR Journal ReviewAmerican College of Rheumatology (ACR)Giant Cell ArteritisGlucocorticoidspatient careprednisonerelapseResearchrheumatologyriskSteroidT celltherapyTreatmentVasculitis

Alendronate Decreases Hip Fracture Risk in Older Patients Using Oral Prednisolone

Lara C. Pullen, PhD  |  August 21, 2017

New research found that older patients on prednisolone who are also treated with alendronate experience a significantly lower risk of hip fracture. Alendronate use was also associated with a lower risk of death…

Filed under:Conditions Tagged with:alendronateelderlyFractureship fracturehip fracture riskprednisolone

Switching from Bisphosphonates to Teriparatide May Improve BMD in Women with RA

Scott Baltic  |  August 19, 2017

NEW YORK (Reuters Health)—Switching women with rheumatoid arthritis (RA) from oral bisphosphonates to teriparatide increases bone mineral density (BMD) and trabecular bone score, according to a new report. Researchers in Japan conducted an 18-month observational study of more than 175 women with RA (mean age: 66) who remained on oral bisphosphonates, switched to denosumab (DMAb),…

Filed under:ConditionsOsteoarthritis and Bone DisordersRheumatoid Arthritis Tagged with:bisphosphonatesbone mineral density (BMD)Osteoporosisosteoporosis treatmentsRheumatoid Arthritis (RA)teriparatideteriparatide treatment for osteoporosisWomen

Rheumatology Drug Updates: Opana ER Painkiller Pulled from U.S. Market; Upadacitinib to Treat RA, and More

Michele B. Kaufman, PharmD, BCGP  |  August 13, 2017

Opana ER Pulled from U.S. Market Last month, the U.S. Food and Drug Administration (FDA) asked Endo Pharmaceuticals to remove oxymorphone hydrochloride extended release (Opana ER) from the U.S. market due to public health consequences related to abuse. The agency has concerns that the risks presented by the treatment do not outweigh its benefits.1 On…

Filed under:Drug UpdatesResearch Rheum Tagged with:abataceptabuseAddictionApprovalsClinicalDrugsEndo PharmaceuticalsFDAMedicationOpana ERopioidoxymorphone hydrochloride extended releasepainkillerResearchresultsSafetytopical diclofenac sodiumtrialupadacitinib

University of Nebraska Division of Rheumatology and Immunology Makes Education, Clinical Research Top Priorities

Gretchen Henkel  |  August 13, 2017

When it was created in 1982, the Division of Rheumatology and Immunology at the University of Nebraska Medical Center comprised one-and-a-half rheumatologists: its founder, Lynell W. Klassen, MD, MACR, and Gerald Moore, MD, who later received formal training at the NIH and now serves as senior associate dean for academic affairs. Thirty-five years later, the…

Filed under:ConditionsEducation & TrainingMyositisProfilesResearch Rheum Tagged with:biobanksClinical researchEducationgout and systemic lupus erythematosusImmunologymyositisRheumatoid arthritisrheumatologySclerodermaTrainingtrialsUniversity of Nebraska

  • « Previous Page
  • 1
  • …
  • 27
  • 28
  • 29
  • 30
  • 31
  • …
  • 58
  • Next Page »
  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
fa-facebookfa-linkedinfa-youtube-playfa-rss
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences